Author

Arian Lundberg

Karolinska InstitutetORCID 0000-0002-6630-2787Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genomics· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Amirhessam Eskafi NoghaniiD· 1 shared Arturo Reyes PalomaresiD· 1 shared Charles M. PerouiD· 1 shared Elinor Löverli· 1 shared Joel S. ParkeriD· 1 shared Jonas C. S. BerghiD· 1 shared Kenny A. Rodriguez-Walberg· 1 shared Linda Sofie LindströmiD· 1 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Amirhessam Eskafi NoghaniORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologyReproductive ToxicologyPeer-reviewedDec 29, 2025

Early gonadotoxic effects of cyclophosphamide on the prepubertal testis and the feasibility of reducing toxicity through combined antioxidant therapy

Amirhessam Eskafi Noghani, Arturo Reyes Palomares, Xia Hao…·Kenny A. Rodriguez-Walberg

This study identifies early gonadotoxic effects of cyclophosphamide on prepubertal testes and shows antioxidant co-treatment can reduce toxicity without compromising anticancer efficacy.

1 citation

mousebulk RNA-seq

GenomicsOncogenePeer-reviewedJun 24, 2020

A pan-cancer analysis of the frequency of DNA alterations across cell cycle activity levels

Arian Lundberg, Linda Sofie Lindström, Joel S. Parker…·Nicholas P. Tobin

The paper analyzes DNA alterations across cell cycle activity levels in 9,515 cancer patients, finding that mutation frequencies vary with cell cycle activity and that cell cycle activity is a prognostic factor.

13 citations

humanwhole-exome sequencing